Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-338511
Filing Date
2026-08-07
Accepted
2026-08-06 17:48:43
Documents
14
Effectiveness Date
2026-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 d939697ds8.htm S-8 46304
2 EX-5.1 d939697dex51.htm EX-5.1 7985
3 EX-23.1 d939697dex231.htm EX-23.1 1994
4 EX-FILING FEES d939697dexfilingfees.htm   iXBRL EX-FILING FEES 15546
5 GRAPHIC g939697g0804220528148.jpg GRAPHIC 3468
  Complete submission text file 0001193125-26-338511.txt   203860

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d939697dexfilingfees_htm.xml XML 7037
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-298092 | Film No.: 261250651
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)